Ortiz, M. V., Gerdemann, U., Raju, S. G., Henry, D., Smith, S., Rothenberg, S. M., . . . Pappo, A. S. (2020). Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations. JCO Precis Oncol.
Styl ChicagoOrtiz, Michael V., et al. "Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations." JCO Precis Oncol 2020.
Citace podle MLAOrtiz, Michael V., et al. "Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations." JCO Precis Oncol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..